| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort.
|
AIDS
|
2005
|
4.40
|
|
2
|
Changing incidence of central nervous system diseases in the EuroSIDA cohort.
|
Ann Neurol
|
2004
|
3.06
|
|
3
|
Subgenotype analysis of Cryptosporidium isolates from humans, cattle, and zoo ruminants in Portugal.
|
J Clin Microbiol
|
2003
|
3.03
|
|
4
|
Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease.
|
AIDS
|
2014
|
2.02
|
|
5
|
Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results.
|
J Infect Dis
|
2013
|
1.90
|
|
6
|
Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial.
|
Antivir Ther
|
2011
|
1.90
|
|
7
|
Baseline susceptibility of primary HIV-2 to entry inhibitors.
|
Antivir Ther
|
2012
|
1.56
|
|
8
|
Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies.
|
Cancer
|
2010
|
1.53
|
|
9
|
Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia.
|
AIDS
|
2006
|
1.52
|
|
10
|
Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.
|
AIDS
|
2007
|
1.51
|
|
11
|
Post-exposure prophylaxis of HIV infection in healthcare workers: recommendations for the European setting.
|
Eur J Epidemiol
|
2004
|
1.50
|
|
12
|
A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.
|
AIDS
|
2003
|
1.43
|
|
13
|
Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results.
|
Clin Infect Dis
|
2007
|
1.39
|
|
14
|
The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.
|
Cancer
|
2004
|
1.39
|
|
15
|
Ritonavir-boosted tipranavir demonstrates superior efficacy to ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients: 24-week results of the RESIST-2 trial.
|
Clin Infect Dis
|
2006
|
1.35
|
|
16
|
Distribution of Cryptosporidium subtypes in humans and domestic and wild ruminants in Portugal.
|
Parasitol Res
|
2006
|
1.34
|
|
17
|
Acute kidney injury in patients with sepsis: a contemporary analysis.
|
Int J Infect Dis
|
2008
|
1.31
|
|
18
|
Long-term risk of mortality after acute kidney injury in patients with sepsis: a contemporary analysis.
|
BMC Nephrol
|
2010
|
1.17
|
|
19
|
Identification of potentially human-pathogenic Enterocytozoon bieneusi genotypes in various birds.
|
Appl Environ Microbiol
|
2006
|
1.13
|
|
20
|
Cryptosporidium felis and C. meleagridis in persons with HIV, Portugal.
|
Emerg Infect Dis
|
2004
|
1.09
|
|
21
|
Acute renal failure in patients with sepsis.
|
Crit Care
|
2007
|
1.09
|
|
22
|
Acute kidney injury in hospitalized HIV-infected patients: a cohort analysis.
|
Nephrol Dial Transplant
|
2011
|
1.05
|
|
23
|
Genotypes of Enterocytozoon bieneusi in mammals in Portugal.
|
J Eukaryot Microbiol
|
2006
|
1.04
|
|
24
|
20 years of HIV-2 infection in Portugal: trends and changes in epidemiology.
|
Clin Infect Dis
|
2009
|
1.04
|
|
25
|
Hepatitis delta in HIV-infected individuals in Europe.
|
AIDS
|
2011
|
0.99
|
|
26
|
Prognostic utility of RIFLE for acute renal failure in patients with sepsis.
|
Crit Care
|
2007
|
0.99
|
|
27
|
Acute renal failure in critically ill HIV-infected patients.
|
Crit Care
|
2007
|
0.97
|
|
28
|
Microsporidia as emerging pathogens and the implication for public health: a 10-year study on HIV-positive and -negative patients.
|
Int J Parasitol
|
2012
|
0.97
|
|
29
|
Population structure of Pneumocystis jirovecii isolated from immunodeficiency virus-positive patients.
|
Infect Genet Evol
|
2010
|
0.94
|
|
30
|
The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients.
|
Retrovirology
|
2008
|
0.93
|
|
31
|
Genetic characterization of the dihydrofolate reductase gene of Pneumocystis jirovecii isolates from Portugal.
|
J Antimicrob Chemother
|
2006
|
0.91
|
|
32
|
The case of the disappearing mycobacteria in Ziehl-Neelsen-stained smears.
|
Int J Infect Dis
|
2011
|
0.90
|
|
33
|
Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe.
|
J Antimicrob Chemother
|
2010
|
0.88
|
|
34
|
Occurrence and molecular characterization of Cryptosporidium spp. in mammals and reptiles at the Lisbon Zoo.
|
Parasitol Res
|
2005
|
0.88
|
|
35
|
An assessment of the RIFLE criteria for acute renal failure in critically ill HIV-infected patients.
|
Crit Care
|
2007
|
0.88
|
|
36
|
Tuberculosis, a re-emergent disease.
|
Eur J Radiol
|
2005
|
0.87
|
|
37
|
Microsporidia detection in stools from pets and animals from the zoo in Portugal: a preliminary study.
|
J Eukaryot Microbiol
|
2003
|
0.87
|
|
38
|
Distribution of Cryptosporidium species and subtypes in water samples in Portugal: a preliminary study.
|
J Eukaryot Microbiol
|
2006
|
0.87
|
|
39
|
Diagnostic use of 3 techniques for identification of microsporidian spores among AIDS patients in Portugal.
|
Scand J Infect Dis
|
2002
|
0.87
|
|
40
|
Identification and determination of the viability of Giardia lamblia cysts and Cryptosporidium parvum and Cryptosporidium hominis oocysts in human fecal and water supply samples by fluorescent in situ hybridization (FISH) and monoclonal antibodies.
|
Parasitol Res
|
2005
|
0.84
|
|
41
|
Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patients.
|
J Virol
|
2010
|
0.84
|
|
42
|
Pneumocystis jirovecii carriage in Portuguese immunocompetent patients: preliminary results.
|
J Eukaryot Microbiol
|
2003
|
0.83
|
|
43
|
Pneumocystis jiroveci in Portuguese immunocompromised patients: association of specific ITS genotypes with treatment failure, bad clinical outcome and childhood.
|
Infect Genet Evol
|
2003
|
0.83
|
|
44
|
Therapeutic potential of caspofungin combined with trimethoprim-sulfamethoxazole for pneumocystis pneumonia: a pilot study in mice.
|
PLoS One
|
2013
|
0.82
|
|
45
|
Microsatellite analysis of Cryptosporidium hominis and C. parvum in Portugal: a preliminary study.
|
J Eukaryot Microbiol
|
2003
|
0.82
|
|
46
|
Direct treatment costs of HIV/AIDS in Portugal.
|
Rev Saude Publica
|
2013
|
0.82
|
|
47
|
Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count>or=300 cells/microL who were assigned to 7.5 MIU interleukin-2.
|
HIV Med
|
2007
|
0.81
|
|
48
|
Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progression.
|
AIDS
|
2008
|
0.81
|
|
49
|
Study of the epidemiology of Pneumocystis carinii f. sp. suis in abattoir swine in Portugal.
|
Med Mycol
|
2012
|
0.79
|
|
50
|
Brief Report: Cobicistat Compared With Ritonavir as a Pharmacoenhancer for Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate: Week 144 Results.
|
J Acquir Immune Defic Syndr
|
2015
|
0.78
|
|
51
|
Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism.
|
AIDS
|
2012
|
0.78
|
|
52
|
Genetic diversity and drug resistance profiles in HIV type 1- and HIV type 2-infected patients from Cape Verde Islands.
|
AIDS Res Hum Retroviruses
|
2011
|
0.77
|
|
53
|
Multilocus genotyping of Pneumocystis jirovecii in immunocompromised patients: preliminary results.
|
J Eukaryot Microbiol
|
2006
|
0.77
|
|
54
|
Long-term risk of mortality for acute kidney injury in HIV-infected patients: a cohort analysis.
|
BMC Nephrol
|
2013
|
0.77
|
|
55
|
Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
|
Clin Immunol
|
2007
|
0.76
|
|
56
|
Tuberculosis with malaria or HIV co-infection in a large hospital in Luanda, Angola.
|
J Infect Dev Ctries
|
2013
|
0.76
|
|
57
|
[Pneumocystis jiroveci infection in immunocompetent patients with pulmonary disorders, in Portugal].
|
Acta Med Port
|
2006
|
0.75
|
|
58
|
HIV-2: the Portuguese connection.
|
Clin Infect Dis
|
2004
|
0.75
|
|
59
|
Neurosyphilis versus Herpes Encephalitis in a Patient with Confusion, Memory Loss, and T2-Weighted Mesiotemporal Hyperintensity.
|
Case Rep Infect Dis
|
2012
|
0.75
|
|
60
|
Antiretroviral therapy for naïve and for treatment-experienced HIV patients, and prevention of HIV transmission.
|
Curr Opin HIV AIDS
|
2011
|
0.75
|
|
61
|
[Multi-drug-resistant tuberculosis in a Department of Infectious Diseases].
|
Acta Med Port
|
2004
|
0.75
|
|
62
|
Is there a gender shift in HCV infection?
|
Int J Infect Dis
|
2005
|
0.75
|
|
63
|
HIV Infection and non-tuberculous mycobacteria: how important in southern European countries?
|
Scand J Infect Dis
|
2004
|
0.75
|
|
64
|
Dihydropteroate synthase (DHPS) genotyping by PCR-RFLP analysis of Pneumocystis jirovecii repeated isolates from HIV-infected patients: a preliminary study.
|
J Eukaryot Microbiol
|
2003
|
0.75
|
|
65
|
Cryptosporidium spp. in ruminants at the Lisbon Zoo.
|
J Zoo Wildl Med
|
2003
|
0.75
|